Back to search
FDAFDA · Food and drugs·Recall number D-0224-2019

BEVACIZUMAB 2.5 MG/0.1ML, pre-filled syringe (deliverable dose of 1.25MG in normject syringe) Repackaged by Avella Specialty Pharmacy, 24416 N 19th Avenue, Pheonix, AZ 85085. NDC 42852-001-24

Published November 14, 2018 · Recall initiated: October 31, 2018

Summary

FDA records drug Class II recall D-0224-2019, published November 14, 2018 and initiated October 31, 2018. Recalling firm: Avella of Deer Valley, Inc. Store 38; Status: Terminated; Reported quantity: 911 syringes; Lot: Lot # 138-20182408@58 BUD 12/22/2018. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Avella of Deer Valley, Inc. Store 38
Distributor
Product was distributed throughout the United States.
Lot
Lot # 138-20182408@58 BUD 12/22/2018
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was BEVACIZUMAB 2.5 MG/0.1ML, pre-filled syringe (deliverable dose of 1.25MG in normject syringe) Repackaged by Avella Specialty Pharmacy, 24416 N 19th Avenue, Pheonix, AZ 85085. NDC 42852-001-24 recalled?

Yes. FDA published recall D-0224-2019 on November 14, 2018. Reported hazard: Lack of Assurance of Sterility

What should I do if I have this product?

Voluntary: Firm initiated · Letter